Peptide substrates recognizable by type e botulinum neurotoxin

[0057]The present invention relates to peptide substrates selectively recognized by botulinum toxin type E, BoNT / E, and their uses, in particular for carrying out methods for detecting, identifying and / or dosing botulinum toxin type E.

Definitions

[0058]The following definitions will be useful in understanding the instant invention.

[0059]As used herein, the term “comprising” is intended to mean that the compositions and methods include the recited elements, but do not exclude other elements. “Consisting essentially of”, when used to define compositions and methods, shall mean excluding other elements of any essential significance to the combination. Thus, a composition consisting essentially of the elements as defined herein would not exclude trace contaminants from the isolation and purification method and pharmaceutically acceptable carriers, such as phosphate buffered saline, preservatives, and the like. “Consisting of” shall mean excluding more than trace elements of other ingred